Tag: Respirion Pharmaceuticals
Partnership between WA, Brandon BioCatalyst set to continue
The Western Australian government announced an additional $2.31 million for a further seven years, or until 2029, to continue its support for life science investment fund Brandon BioCatalyst, to which it has given $2.52 million since 2008.
Featured Article
The economic forces driving manufacturing’s next cycle
Australia’s manufacturing sector entered 2026 with improving momentum, but renewed global disruption is again testing resilience across the industry.
